Keyphrases
Blood Substitutes
100%
21st Century
100%
Europe
100%
European Citizens
28%
Transfusion
28%
SMEs
14%
Long-term Benefit
14%
Commercially Viable
14%
Technological Platform
14%
Preservers
14%
Mixed-sex
14%
Physiological Assessment
14%
Commerce
14%
Biochemical Characterization
14%
Biologic Materials
14%
Framework Programme
14%
Oxygen Carrier
14%
Biophysical Characterization
14%
Variant Hemoglobin
14%
Blood Utilization
14%
Developing Strategy
14%
Genomic Research
14%
Quality of Life
14%
Cell Factory
14%
Creutzfeldt-Jakob Disease
14%
Postgenomics
14%
Efficient Generation
14%
Industrialists
14%
Optimization Strategy
14%
Haem Protein
14%
Blood Transfusion
14%
Academic Scientists
14%
Purification Characterization
14%
European Countries
14%
Blood Safety
14%
Blood Components
14%
European People
14%
Modified Hemoglobin
14%
Medicine and Dentistry
Blood Substitute
100%
Quality of Life
14%
Hemeprotein
14%
Biocompatible Material
14%
Copurification
14%
Diseases
14%
Blood Transfusion
14%
Variant Creutzfeldt-Jakob Disease
14%
Blood Component
14%
Blood Safety
14%
Hemoglobin Variant
14%
Human Immunodeficiency Virus
14%
Consultation
14%
Clinician
14%
Nursing and Health Professions
Blood Substitute
100%
Hemoglobin Variant
14%
Blood Safety
14%
Biomaterial
14%
Human Immunodeficiency Virus
14%
Hemoprotein
14%
Variant Creutzfeldt Jakob Disease
14%
Quality of Life
14%
Clinician
14%
Blood Transfusion
14%
Disease
14%